Form 4 AI
Back to all filings

Form 4 · Filed Jul 31, 2026, 08:18 PM UTC

UTHR/UNITED THERAPEUTICS Corp

ROTHBLATT MARTINE A — Chairperson & CEO

AI Thesis

A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.

Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.

Transactions

8 rows
DateCodeDirectionSharesPriceValueOwned after
Jul 30, 2026Mother9,500$135$1,286,490333,943
Jul 30, 2026Ssell644$523$336,837333,299
Jul 30, 2026Ssell1,486$524$778,478331,813
Jul 30, 2026Ssell4,846$525$2,543,589326,967
Jul 30, 2026Ssell2,084$526$1,095,763324,883
Jul 30, 2026Ssell400$527$210,769324,483
Jul 30, 2026Ssell40$529$21,158324,443
Jul 30, 2026Mother9,500236,910

Source: SEC EDGAR raw filing ↗ · Accession 0001106578-26-000110

UTHR Form 4 — ROTHBLATT MARTINE A — Form 4 AI